GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Centerspan Communications SUVZ · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Centerspan Communications — daily SUVZ Delayed
Market value
$22
Last close × shares
Volume
649
Shares, 30 Oct 2026

About Centerspan Communications

Its shares trade under the ticker SUVZ.

Suvanza operates as an early-stage biotechnology company. The company is headquartered in Hillsboro, Oregon. The firm provides topical treatment with Mycophin anti-Fungal Gel. The company has successfully completed clinical trials, for such indications as Onychomycosis, Tinea Capitis and Tinea Corporis. Suvanza’s delivery system uses less active ingredients, has reduced systemic uptake, and provides the opportunity to use multiple actives, which do not interact prior to application. The Company’s Technology consists of three components: Active Ingredient, Macro Bead Technology and Protecting Gel Vehicle. The Active Ingredient uses physical chemical modulation in nano vesicle formulation, for a targeted penetration in skin, hair and nails diseases. The Suvanza Technology targets disease sites such as skin surface, hair and nails, filling a void in topical therapy in those areas.

Figures and description from our data supplier, not checked against the company's own report.

More about Centerspan Communications →

Latest on Centerspan Communications

Our reporting

We have not reported on Centerspan Communications yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Centerspan Communications's ticker?

Centerspan Communications trades as SUVZ on its US listing, under ISIN US8695511019.

What was Centerspan Communications's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.